Donanemab was found to slow "clinical decline" by up to 35%, allowing people with the disease to continue performing day-to-day tasks.

https://news.sky.com/story/new-drug-found-to-slow-alzheimers-hailed-a-turning-point-in-fight-against-disease-12922313